Kintara Therapeutics, Inc.

Kintara Therapeutics, Inc.

KTRA
Kintara Therapeutics, Inc.US flagNASDAQ Capital Market
0.22
USD
-0.01
- -
11.99MMarket Cap

Kintara Therapeutics, Inc. (KTRA) Stock Split History

Learn about Kintara Therapeutics, Inc.'s most recent 1-for-50 basis stock split on November 14, 2022. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Kintara Therapeutics, Inc.'s most recent stock split

Split Date: 2022-11-14
Split Ratio: 1:50
Price Before Split: $0.79
Price After Split: $0.02

Developer API

Get KTRA split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/KTRA

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 50.00 times fewer shares (a 1:50 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Kintara Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-11-141:50Yes$0.79$0.02
2019-05-081:10Yes$2.92$0.29
2016-05-201:4Yes$11.83$2.96

About Kintara Therapeutics, Inc.

Company overview and industry information

Kintara Therapeutics, Inc. (KTRA) operates in the Biotechnology industry. The recent 1-for-50 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Kintara Therapeutics, Inc. Summary

Last updated: 7/8/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.